Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belimumab”

104 trials

Showing 20 of 104 results

Testing effectiveness (Phase 2)UnknownNCT03967925
What this trial is testing

Rituximab and Belimumab Combination Therapy in PR3 Vasculitis

Who this might be right for
ANCA Associated VasculitisGranulomatosis With Polyangiitis
Rachel Jones 31
Early research (Phase 1)Study completedNCT01516450
What this trial is testing

Japanese phase1 Study of Belimumab (IV vs SC)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 16
Not applicableStudy completedNCT03370263
What this trial is testing

BENLYSTA® Special Drug Use Investigation

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 1,514
Testing effectiveness (Phase 2)Study completedNCT01008982
What this trial is testing

Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
University of Udine 15
Testing effectiveness (Phase 2)Study completedNCT02500251
What this trial is testing

Belimumab Impacting Transplant Eligibility

Who this might be right for
Renal Transplant Rejection
E. Steve Woodle 11
Testing effectiveness (Phase 2)Ended earlyNCT03591380
What this trial is testing

CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
University of Wisconsin, Madison 3
Testing effectiveness (Phase 2)Study completedNCT01160666
What this trial is testing

Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
Assistance Publique - Hôpitaux de Paris 20
Testing effectiveness (Phase 2)Study completedNCT00583362
What this trial is testing

A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 298
Early research (Phase 1)Study completedNCT01894360
What this trial is testing

Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 81
Testing effectiveness (Phase 2)Study completedNCT03244059
What this trial is testing

Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies

Who this might be right for
Chronic Obstructive Pulmonary DiseaseEmphysema
University of Alabama at Birmingham 17
Testing effectiveness (Phase 2)Study completedNCT01610492
What this trial is testing

Belimumab in Idiopathic Membranous Glomerulonephropathy

Who this might be right for
Glomerulonephritis, Membranous
GlaxoSmithKline 14
Post-approval studies (Phase 4)UnknownNCT04447053
What this trial is testing

Sequential Belimumab and T-cell Based Therapy in SLE

Who this might be right for
Systemic Lupus Erythematosus
National University Hospital, Singapore 80
Post-approval studies (Phase 4)UnknownNCT04893161
What this trial is testing

A Model About the Response of Belimumab in SLE

Who this might be right for
Systemic Lupus Erythematosus
First Affiliated Hospital Xi'an Jiaotong University 72
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Not applicableNot Yet RecruitingNCT04671706
What this trial is testing

Belimumab in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Fundación Española de Medicina 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT06747312
What this trial is testing

Effect of Belimumab on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Large-scale testing (Phase 3)Study completedNCT00410384
What this trial is testing

Belimumab in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 819
Not applicableLooking for participantsNCT07056621
What this trial is testing

Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study

Who this might be right for
SLE - Systemic Lupus Erythematosus
Biomedical Research Foundation, Academy of Athens 684
Large-scale testing (Phase 3)Looking for participantsNCT06572384
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Who this might be right for
Lung Diseases, Interstitial
GlaxoSmithKline 440
Testing effectiveness (Phase 2)Looking for participantsNCT06381453
What this trial is testing

Belimumab in Autoimmune Hepatitis

Who this might be right for
Autoimmune Hepatitis
University Health Network, Toronto 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation